Given the common roles of the BRCA gene products in genomic maintenance, this suggests that phenotypic differences between BRCA1- and BRCA2-associated tumours impose selective advantages for distinct genomic alterations in the context of instability generated by BRCA-deficiency. Here, BRCA2 is linked to neoplasm.